Search - tctmd.com

Displaying 1 - 20 of 277

Sort: Relevancy | Date

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 1013: Incidence of in-stent thrombotic events in patients undergoing percutaneous coronary intervention (PCI) with stent placement started on dual antiplatelet therapy (DAPT)

Presenter: Sulayma Naser Agha

October 28, 2025

Presentation TCT 2025

TCT 1011: Feasibility Study of Local Antiplatelet Therapy Using an Arterial infusion microcatheter (AIMC) for the Prevention of In-Stent Thrombosis

Presenter: Yi Mao

October 28, 2025

Presentation TCT 2025

TCT 1016: Temporal Modulation of Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention for Highly Complex Anatomy: A Post-hoc Analysis of the TAILORED-CHIP Trial

Presenter: Do-Yoon Kang

October 28, 2025

Presentation TCT 2025

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

Presenter: Seong-Bong Wee

October 28, 2025

Presentation TCT 2025

TCT 1852: Case Report: Spontaneous Large Thoracic Hematoma in a Patient on Antiplatelet Therapy

Presenter: Soo-Young Lee

October 28, 2025

Presentation TCT 2025

TCT 1006: Dual Antiplatelet Therapy Duration and Risk of Stent Thrombosis in Complex Percutaneous Coronary Intervention: a Meta-Analysis

Presenter: Fiorenzo Simonetti

October 27, 2025

Presentation TCT 2025

TCT 1007: Short Vs. Long Dual Antiplatelet Therapy for Chronic Total Occlusions Coronary Interventions: A systematic Review and Bayesian Meta-Analysis

Presenter: Ricardo Fonseca Oliveira Suruagy-Motta

October 27, 2025

Presentation TCT 2025

TCT 995: Less Is More? P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy following PCI In Acute Coronary Syndrome: A Meta-Analysis of Reconstructed Time-to-Event Data

Presenter: Paulo Roberto Tartuce Filho

October 27, 2025

Presentation TCT 2025

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

Presenter: Kanishk Aggarwal

October 27, 2025

Presentation TCT 2025

TCT 1823: Drug-Coated Balloon Treatment Despite an Angiographic Dissection to Avoid Dual Antiplatelet Therapy in a Patient Needing Vascular Surgery in Short Time

Presenter: Marco Luciano Rossi

October 26, 2025

Presentation TCT 2025

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

Presenter: Zeyad Kholeif

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

Presenter: Rakendu Jayasree Rajendran

October 25, 2025

Presentation TCT 2025

Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study

Presenter: Hyo-Soo Kim

October 25, 2025

Presentation ESC 2025

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Presenter: David Newby

September 03, 2025

Presentation ESC 2025

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Presenter: Anders Jeppsson

September 01, 2025

Presentation ESC 2025

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

Presenter: Duk-Woo Park

August 31, 2025

Presentation ESC 2025

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Presenter: Pedro A. Lemos

August 30, 2025

Presentation ACC 2025

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Presenter: Hyo-Soo Kim

March 29, 2025

Advertisement

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

TCT 1013: Incidence of in-stent thrombotic events in patients undergoing percutaneous coronary intervention (PCI) with stent placement started on dual antiplatelet therapy (DAPT)

TCT 1011: Feasibility Study of Local Antiplatelet Therapy Using an Arterial infusion microcatheter (AIMC) for the Prevention of In-Stent Thrombosis

TCT 1016: Temporal Modulation of Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention for Highly Complex Anatomy: A Post-hoc Analysis of the TAILORED-CHIP Trial

TCT 493: Tailored Antiplatelet Therapy in High-Risk Diabetic Patients Undergoing Complex Percutaneous Coronary Intervention: The Prespecified Analysis of TAILORED-CHIP Trial

TCT 1852: Case Report: Spontaneous Large Thoracic Hematoma in a Patient on Antiplatelet Therapy

TCT 1006: Dual Antiplatelet Therapy Duration and Risk of Stent Thrombosis in Complex Percutaneous Coronary Intervention: a Meta-Analysis

TCT 1007: Short Vs. Long Dual Antiplatelet Therapy for Chronic Total Occlusions Coronary Interventions: A systematic Review and Bayesian Meta-Analysis

TCT 995: Less Is More? P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy following PCI In Acute Coronary Syndrome: A Meta-Analysis of Reconstructed Time-to-Event Data

TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis.

TCT 1823: Drug-Coated Balloon Treatment Despite an Angiographic Dissection to Avoid Dual Antiplatelet Therapy in a Patient Needing Vascular Surgery in Short Time

TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes

Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study

Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes: The DUAL-ACS Trial

Dual or single antiplatelet therapy after coronary artery bypass grafting in patients with acute coronary syndrome: The TACSI trial

Tailored Antiplatelet Therapy in High-Risk Patients Undergoing Complex PCI: The TAILORED-CHIP Randomized Clinical Trial

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Dual Antiplatelet Therapy After PCI According To Bleeding Risk: HOST-BR RCT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content